{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:25:51Z","timestamp":1791116751813,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.nbd.2006.09.015","type":"journal-article","created":{"date-parts":[[2006,11,8]],"date-time":"2006-11-08T12:34:18Z","timestamp":1162989258000},"page":"342-353","source":"Crossref","is-referenced-by-count":26,"title":["Systemic administration of Congo red does not improve motor or cognitive function in R6\/2 mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Nigel I.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick N.","family":"Pallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wanderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Jennifer","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2006.09.015_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/jmg.2003.014548","article-title":"Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy","volume":"41","author":"Bao","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2006.09.015_bib2","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2006.09.015_bib3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z","article-title":"Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington\u2019s disease gene","volume":"15","author":"Carter","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2006.09.015_bib4","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1128\/JVI.77.9.5499-5502.2003","article-title":"Inhibition of protease-resistant prion protein accumulation in vitro by curcumin","volume":"77","author":"Caughey","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2006.09.015_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/502","article-title":"Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1","volume":"19","author":"Cummings","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2006.09.015_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2006.09.015_bib7","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2006.09.015_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1748-1716.1965.tb04062.x","article-title":"Blood\u2013brain barrier alteration after experimental cold injury of the rabbit brain, indicated by penicillin G in EEG and by dye tests","volume":"63","author":"Flodmark","year":"1965","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.nbd.2006.09.015_bib9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1748-1716.1963.tb02659.x","article-title":"Reversible blood\u2013brain barrier alteration induced by certain organic acids and indicated by means of EEG and dye tests","volume":"58","author":"Flodmark","year":"1963","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.nbd.2006.09.015_bib10","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/hmg\/ddg249","article-title":"Complexin II is essential for normal neurological function in mice","volume":"12","author":"Glynn","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.09.015_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0166-4328(01)00275-3","article-title":"Development of SHIRPA to characterise the phenotype of gene-targeted mice","volume":"125","author":"Hatcher","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2006.09.015_bib12","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1073\/pnas.110138997","article-title":"Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington\u2019s disease therapy","volume":"97","author":"Heiser","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2006.09.015_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2006.09.015_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0197-4580(94)90050-7","article-title":"Development of small molecule probes for the beta-amyloid protein of Alzheimer\u2019s disease","volume":"15","author":"Klunk","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2006.09.015_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0197-4580(95)00058-M","article-title":"Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe","volume":"16","author":"Klunk","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2006.09.015_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","article-title":"New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins","volume":"56","author":"Ko","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2006.09.015_bib17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntingtin aggregates may not predict neuronal death in Huntington\u2019s disease","volume":"46","author":"Kuemmerle","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2006.09.015_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0197-4580(02)00121-5","article-title":"Amyloid binding ligands as Alzheimer\u2019s disease therapies","volume":"23","author":"Lee","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2006.09.015_bib19","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2006.09.015_bib20","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/01.WNL.0000086373.32347.16","article-title":"Huntington\u2019s disease. Clinical correlates of disability and progression","volume":"61","author":"Mahant","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2006.09.015_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2006.09.015_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","article-title":"Disintegration of the sleep\u2013wake cycle and circadian timing in Huntington\u2019s disease","volume":"25","author":"Morton","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2006.09.015_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1460-9568.2005.03895.x","article-title":"A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington\u2019s disease","volume":"21","author":"Morton","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2006.09.015_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0304-3940(93)90168-K","article-title":"CSF and serum metabolic profile of patients with Huntington\u2019s chorea: a study by high resolution proton NMR spectroscopy and HPLC","volume":"154","author":"Nicoli","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2006.09.015_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","article-title":"Inhibition of caspase-1 slows disease progression in a mouse model of Huntington\u2019s disease","volume":"399","author":"Ona","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2006.09.015_bib26","doi-asserted-by":"crossref","first-page":"41032","DOI":"10.1074\/jbc.M205809200","article-title":"Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization","volume":"277","author":"Poirier","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2006.09.015_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-0270(97)00168-4","article-title":"Changes in blood\u2013brain barrier permeability following neurotoxic lesions of rat brain can be visualised with Trypan blue","volume":"79","author":"Reynolds","year":"1998","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2006.09.015_bib28","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/j.1460-9568.2004.03783.x","article-title":"Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington\u2019s disease mutation","volume":"20","author":"Ribchester","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2006.09.015_bib29","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","article-title":"The association of CAG repeat length with clinical progression in Huntington disease","volume":"66","author":"Rosenblatt","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2006.09.015_bib30","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1099\/0022-1317-81-4-1155","article-title":"Screening Congo red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells","volume":"81","author":"Rudyk","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.nbd.2006.09.015_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0024-3205(92)90023-I","article-title":"Blood\u2013brain barrier dysfunctions following systemic injections of kainic acid in the rat","volume":"51","author":"Saiji","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2006.09.015_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"Sanchez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2006.09.015_bib33","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","article-title":"Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington\u2019s disease pathology","volume":"96","author":"Scherzinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2006.09.015_bib34","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1073\/pnas.97.13.7609","article-title":"In vivo detection of amyloid plaques in a mouse model of Alzheimer\u2019s disease","volume":"97","author":"Skovronsky","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2006.09.015_bib35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1006\/nbdi.2001.0438","article-title":"Inhibition of polyglutamine aggregation in R6\/2 HD brain slices\u2014Complex dose\u2013response profiles","volume":"8","author":"Smith","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2006.09.015_bib36","series-title":"Behavioural Neuroscience: A Practical Approach","first-page":"107","article-title":"The watermaze","author":"Stewart","year":"1993"},{"key":"10.1016\/j.nbd.2006.09.015_bib37","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1177\/002215540004800906","article-title":"X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer\u2019s disease pathology","volume":"48","author":"Styren","year":"2000","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.nbd.2006.09.015_bib38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2006.09.015_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0361-9230(03)00141-2","article-title":"Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington\u2019s disease mutation","volume":"61","author":"Wood","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2006.09.015_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996106002452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996106002452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T08:30:19Z","timestamp":1555921819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996106002452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0969996106002452"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2006.09.015","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}